Concerns over safety, a tough regulatory environment and a highly competitive pharmaceutical market continue to drive demand for large clinical trials.

International clinical trials

And these large clinical trials are increasingly taking place in developing countries; owing mainly to lower costs, more willing participants and the presence of patients with varied diseases. Indeed, many clinical trials now take place in multiple developing countries simultaneously.

This has created the need for a specialist medical translation service that uses local, highly trained medical translators with scientific backgrounds. At Conversis, we have on our books professional medical translators based in more than 50 countries.

We have also developed a streamlined process for the translation, review and approval through local ethics committees for all patient and investigator materials related to the clinical trial.

We tailor our process to meet the needs of each client and every new project, but here is an example of how we would conduct a typical clinical trial:

About Gary Muddyman

Conversis CEO Gary Muddyman has written a number of articles on the consideration of translation and localisation in international clinical trials. Read more here:

 

Cultural Dimensions, by Gary Muddyman in International Clinical Trials

 

Avoiding PR Disaster, by Gary Muddyman in BioBusiness Development

Localisation process flow for international clinical trials